Tuesday, 05 July 2022

Redcliffe Labs appoints Sanjay Bhargava as Director M&A & Growth

03 May 2022 | News

Bhargava will lead inorganic and organic growth opportunities across the gamut of diagnostic services

Redcliffe Labs, a unit of Redcliffe Lifetech in the US and India, has recently announced Sanjay Bhargava as its Director M&A & Growth.

Bhargava comes with over 30 years of experience across different verticals of healthcare such as pharma, diagnostics and hospitals. 

Bhargava is a Gold Medallist in Bachelors in Pharmacy from Nagpur University with a Certification in Finance from IIM Bangalore.

 

Bhargava will lead inorganic and organic growth opportunities across the gamut of diagnostic services, driving consolidation strategy to scale up the business operations, building professional management growth teams, and transforming business management practices. 

 

He started his career as a Medical Representative with Crosslands and Cadila, before he moved into diagnostics and was instrumental in establishing and scaling up companies like Pathnet, Wellspring (Piramal Diagnostics), launching and Heading the M&A and HLM vertical for Dr Lal Path Labs, before opening his own entrepreneurial venture HealthSquare. After which he worked at Moolchand Healthcare, International Oncology, Mirable Diagnostics (Human Health) Bengaluru , NGIVD, and Gian Health Care as CEO. 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account